Latest news

Thumbnail image for Shire’s HAE drug Firazyr cleared for children

Shire’s HAE drug Firazyr cleared for children

European regulators have approved a label extension for Shire’s Firazyr, broadening its use include adolescents and children aged two years and older with a particular type of HAE.

27th October 2017

Thumbnail image for New products boost Q3 sales at GSK

New products boost Q3 sales at GSK

GlaxoSmithKline has posted a near 4 percent rise in sales for the third quarter of the year, driven by a solid performance by its HIV and respiratory therapies and a weak pound.

26th October 2017

Thumbnail image for FDA rejects PTC’s DMD drug Translarna

FDA rejects PTC’s DMD drug Translarna

PTC Therapeutics will need to carry out at least one further trial to demonstrate the effectiveness of its Duchenne Muscular Dystrophy therapy Translarna if it is to have a chance of bagging its approval in the US.

26th October 2017

Thumbnail image for CDC committee favours GSK’s shingles vaccine

CDC committee favours GSK’s shingles vaccine

The US Centre for Disease Control Prevention's Advisory Committee on Immunisation Practices (ACIP) has given its backing to GlaxoSmithKline’s newly approved shingles vaccine Shingrix over Merck & Co’s veteran vaccine Zostavax.

26th October 2017

Thumbnail image for Horizon Pharma enrolls first patient in TED trial

Horizon Pharma enrolls first patient in TED trial

Horizon Pharma has enrolled the first patient in a Phase III clinical trial assessing its experimental medicine teprotumumab for moderate-to-severe active thyroid eye disease (TED).

26th October 2017

Thumbnail image for Gilead presents promising data for NASH drug

Gilead presents promising data for NASH drug

Gilead has presented promising Phase II results for its experimental NASH drug GS-0976, showing significant reductions in the build up of liver fat and a marker of fibrosis.

25th October 2017

Thumbnail image for UK start-up Echo raises £7m to grow apps business

UK start-up Echo raises £7m to grow apps business

UK startup Echo, which recently launched an app enabling patients to order repeat NHS prescriptions from their smartphone, has raised £7 million in venture capital funding to help grow its offering.

25th October 2017

Thumbnail image for US expands use of Alexion rare disease therapy Soliris

US expands use of Alexion rare disease therapy Soliris

Alexion’s rare disease therapy Soliris can now be used in the US to treat generalised myasthenia gravis in patients who are anti-acetylcholine receptor antibody-positive, offering this group the first new treatment option in more than 60 years.

25th October 2017

Previous  --   14 15 16 17 18 19 20 21 22 23   --  Next

Download our apps

Go to the App Store or Google Play and search for 'PharmaTimes' to download our free app.

Go to the App Store or Google Play and search for 'PharmaTimes' to download our free app.

Download